Prix Yunkang Group Limited (02325.HK)

Yunkang Group Ltd. is an investment holding company, which engages in the provision of diagnostic testing services. The company is headquartered in Guangzhou, Guangdong and currently employs 1,146 full-time employees. The company went IPO on 2022-05-18. The Company’s service portfolio mainly includes three services. The diagnostic outsourcing services engages in the provision of diagnostic outsourcing services to hospitals, other medical institutions and public health institutions. The diagnostic testing services for medical institution alliances engages in assisting hospitals to establish on-site diagnostic centers through joint collaboration in main disease areas such as infectious diseases, reproductive health, genetic diseases and pathology, and the provision of comprehensive solutions including testing technologies, professional technicians and others to hospitals. The diagnostic testing services for non-medical institutions engages in the provision of personalized diagnostic testing, medical report consultation services and hospital referral services. The firm conducts its business in the domestic market.